Dialyzer Market Report

Global Dialyzer Market Size

The global dialyzer market was worth USD 3819.99 million in 2024. The market is expected to reach USD 7011.09 million by 2033 from USD 4086.63 million in 2025, growing at a CAGR of 6.98% from 2025 to 2033.

A dialyzer is a medical device that replaces kidney function by using an artificial membrane to remove excess water and metabolic wastes from the blood. Dialyzers are primarily used by healthcare professionals for hemodialysis. Patients may need this treatment three to four times a week. According to the treatment, it is divided into intermittent hemodialysis treatment and continuous hemodialysis treatment.

In addition to replacement therapy for chronic renal failure, it is also widely used in various causes of acute renal failure, multiple organ failure, severe trauma, acute necrotizing pancreatitis, hyperkalemia, hypernatremia, and acute alcoholism. Relieving the patient's symptoms and prolonging the survival time has a certain meaning, but also one of the effective measures to save acute and chronic renal failure.

MARKET DRIVERS

The increase in the number of patients suffering from diabetes and hypertension is driving the growth of the global dialyzer market. People with chronic conditions primarily choose dialysis over transplantation due to complications from kidney transplantation. The market is driven by an increasing prevalence of kidney disease around the world, a growing geriatric population, effective treatments, and changing lifestyles.

According to the Population Division of the United Nations Department of Economic and Social Affairs, between 2015 and 2019, the world's population aged 60 and over increased by 70% in urban areas and 28% in rural areas. Renal efficiency decreases with age; therefore, the geriatric population is more prone to renal failure. According to the Global Kidney Health Atlas, in 2018, one in three people over the age of 60 had an increased risk of chronic kidney disease, and about 32% had chronic kidney disease. In addition, 9 out of 10 people with chronic kidney disease are unaware of their condition. The uptake of hemodialysis machines is likely to increase in developing countries in response to favorable environmental conditions.

According to the World Health Organization (WHO), in 2019, around 4.3 million people suffered from chronic kidney disease worldwide. Disposable blood dialyzers also benefit patients by reducing reuse syndromes caused by residual germicides. According to the National Kidney Foundation, about 3.2 million patients depend on regular life-saving dialysis treatment, either at a dialysis clinic or at home to prevent damage to other organs caused by the build-up of toxins in the blood, and this number increases by between five and six percent each year. The risk associated with chronic disease can lead to cancer, diabetes and high blood pressure. Additionally, people prefer to go for dialysis rather than kidney transplants, taking into account the costs and complications associated with transplants. Again, the number of donors is limited, which in turn will cause kidney patients to turn to dialysis, thus driving the global dialyzer market.

Rising cases of kidney disorders such as chronic kidney disease (CRF) and end-stage renal disease (ESRD) are the vital factors driving the market growth, along with the positive reimbursement framework and technical advancement of machines expand the dialyzer market. In addition, kidney disease is associated with a huge financial burden. According to the GBD study, high-income countries typically spend more than 2.5% to 3.5% of the annual healthcare budget on the treatment of end-stage renal disease, which is expected to drive the hemodialysis market. The modernization and huge revenue generation will create even more opportunities for the dialyzer market during the period 2024-2032.

MARKET RESTRAINTS

Complications and risks associated with hemodialysis procedures such as severe anemia and fluid overload will restrain the dialyzer market during the forecast period.

Certain factors such as the rising cost of dialyzers and stringent regulatory requirements are likely to constrain the dialyzer market. Furthermore, the increased reuse of dialyzers is expected to inhibit the dialyzer market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Type Insights

The growing demand for dialysis products in patients with chronic renal failure, the increased focus on advanced healthcare, and the growing preference of patients to opt for dialysis treatment is one of the factors likely to stimulate the growth of the segment.

By End-User Insights

The dialyzer market is divided between center dialysis and home dialysis. The center dialysis segment had the largest dialyzer market share in 2023. The segment is expected to remain dominant during the projected period. This is attributed to the availability of trained medical personnel in the dialysis centers, which helps to provide better services to the patients and contributes to the growth of the dialyzer market.

REGIONAL ANALYSIS

Geographically, the North American dialyzer market is predicted to play a dominating role in the global market during the forecast period. In North America, the increasing prevalence of end-stage renal disease (ESRD), diabetes, and hypertension makes it a favorable market for dialyzers. Favorable government policies such as, the US government passing legislation that extended Medicare coverage to patients of all age groups with ESRD, the US Department of Health and Human Services (HHS) and the American Society for Nephrology (ASN) hosted a KidneyX: Dialysis Redesign competition with a cash prize. The competition has forced manufacturers to develop better treatment options for patients with kidney failure. Hence the enriching innovations in the field of dialysis and dialyzer membranes to rethink the treatment of renal failure.

The European dialyzer market is expected to be the second-largest regional market during the forecast due to the growing geriatric population, the increasing prevalence of kidney disease, and the increasing adoption of new products to treat kidney disease. According to the NHS Blood and Transplant Kidney Transplant Study, around 4,900 patients in the UK were on the waiting list for kidney transplants in 2020.

According to the NKF, in 2019, 15% of the Asia-Pacific region's population, made up of one in five men and one in four women, were affected by chronic kidney disease and millions of people die each year from the disease owing to the lack of access to affordable treatment. Hence, the Asia-Pacific market will grow with the highest CAGR during the forecast period. Asia-Pacific is the expected region in terms of the growth of the dialyzer market. The Asian region is seen as an emerging market for dialyzers, due to the presence of developing economies, rising health care spending, and an ever-growing population. China and India are expected to experience significant growth in the dialyzer market, owing to the increase in the number of patients and the increase in medical tourism for various surgeries in the region. For example, according to the Directorate General of Economic Intelligence and Statistics of India, in 2018-2019, Indian hospitals registered 470,000 international patients.

The LATAM region is predicted to see a promising growth rate during the forecast period due to its growing healthcare infrastructure. The Middle East will dominate the LATAM dialyzer market due to the increasing incidence of kidney disease, improved diagnostics, rising health expenditure per capita, and high disposable income of the region's population.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the global dialyzer market include

• Asahi Kasei Corp.
• B. Braun Melsungen AG
• Baxter International Inc.
• Medtronic Plc
• JMS Co. Ltd
• Kawasumi Laboratories Inc.
• Fresenius Medical Care AG and Co. KGaA
• Nikkiso Co. Ltd.
• Nipro Corp.
• Toray Industries Inc.

RECENT MARKET DEVELOPMENTS

• In March 2018, NephroPlus, the largest dialysis service provider in India, successfully achieved a milestone in the field of dialysis by taking up 2 million dialysis sessions.

• In May 2018, Fresenius Medical Care took over a nearly 70% stake in the Guangzhou-based Medical Investment Co., Ltd., which holds products for dialyzers and chronic disease services.

• In June 2018, the USFDA authorized the marketing of two catheter-based dialyzers, the Ellipsys Vascular Access System and the everlinQ endoAVF System, designed to create a connection with the veins and arteries in patients with chronic kidney disease requiring hemodialysis.

• In January 2019, Fresenius Medical Care introduced the latest 4008A dialysis machine, specially designed to meet the needs of a growing market. With the launch of this dialyzer, the main aim is to improve the accessibility of dialysis treatments for critical patients living with end-stage renal disease (ESRD).

MARKET SEGMENTATION

This research report on the global dialyzer market has been segmented and sub-segmented based on type, end-user, and region.

By Type

• High-Flux
• Low-Flux

By End-User

• In the Center Dialyzer
• Home Dialyzer

By Region

• North America
• Europe
• Asia-pacific
• Latin America
• Middle East and Africa